Apr 19, 2023
Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors
Mar 03, 2023
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2022 Financial Results
Mar 01, 2023
Keros Therapeutics to Present at Cowen’s 43rd Annual Health Care Conference
Feb 07, 2023
Keros Therapeutics to Present at the SVB Securities Global Biopharma Conference
Displaying 11 - 14 of 14